Belite Bio (BLTE) Total Liabilities (2020 - 2026)

Belite Bio's Total Liabilities history runs 7 years deep, the most recent figure standing at $15.5 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 152.54% year-over-year to $15.5 million; the TTM figure through Mar 2026 stood at $15.5 million (up 152.54% YoY), while the FY2025 annual figure was $10.1 million, up 59.56% from the prior year.
• Total Liabilities was $15.5 million for Q1 2026 at Belite Bio, up from $10.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $15.5 million in Q1 2026 to a low of $2.8 million in Q4 2022.
• Historically, Total Liabilities has averaged $6.2 million across 5 years, with a median of $4.9 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Total Liabilities slipped 24.63% in 2024, then surged 152.54% in 2026.
• A 5-year view of Total Liabilities shows it stood at $2.8 million in 2022, then soared by 51.91% to $4.2 million in 2023, then surged by 49.87% to $6.3 million in 2024, then surged by 59.56% to $10.1 million in 2025, then soared by 53.75% to $15.5 million in 2026.
• The last three Total Liabilities figures came in at $15.5 million (Q1 2026), $10.1 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.